South Carolina’s Nephron Pharmaceuticals Corporation- known for developing and producing affordable generic inhalation solutions and suspension products, including those used to treat severe respiratory distress symptoms associated with COVID-19 - has announced an investment of $215m in Lexington County which will help the company add a new vaccine production space, apart from a new office and warehouse, in the county’s Saxe-Gotha Industrial Park.
Henry McMaster, Governor of South Carolina commented, “This new investment of more than $215m creating 380 new jobs (by 2024)...




